Penetrating traumatic brain injury (PTBI) is a significant cause of death and disability in the United States. Inflammasomes are one of the key regulators of the interleukin (IL)–1β mediated inflammatory responses after traumatic brain injury. However, the contribution of inflammasome signaling after PTBI has not been determined. In this study, adult male Sprague-Dawley rats were subjected to sham procedures or penetrating ballistic-like brain injury (PBBI) and sacrificed at various time-points. Tissues were assessed by immunoblot analysis for expression of IL-1β, IL-18, and components of the inflammasome: apoptosis-associated speck-like protein containing a caspase-activation and recruitment domain (ASC), caspase-1, X-linked inhibitor of apoptosis protein (XIAP), nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3), and gasdermin-D (GSDMD). Specific cell types expressing inflammasome proteins also were evaluated immunohistochemically and assessed quantitatively. After PBBI, expression of IL-1β, IL-18, caspase-1, ASC, XIAP, and NLRP3 peaked around 48 h. Brain protein lysates from PTBI animals showed pyroptosome formation evidenced by ASC laddering, and also contained increased expression of GSDMD at 48 h after injury. ASC-positive immunoreactive neurons within the perilesional cortex were observed at 24 h. At 48 h, ASC expression was concentrated in morphologically activated cortical microglia. This expression of ASC in activated microglia persisted until 12 weeks following PBBI. This is the first report of inflammasome activation after PBBI. Our results demonstrate cell-specific patterns of inflammasome activation and pyroptosis predominantly in microglia, suggesting a sustained pro-inflammatory state following PBBI, thus offering a therapeutic target for this type of brain injury.
LinD.J., LamF.C., SiracuseJ.J., ThomasA., and KasperE.M. (2012). “Time is brain ” the Gifford factor - or: why do some civilian gunshot wounds to the head do unexpectedly well? A case series with outcomes analysis and a management guide. Surg. Neurol. Int., 3, 98.
3.
GerberL.M., ChiuY.L., CarneyN., HärtlR., and GhajarJ. (2013). Marked reduction in mortality in patients with severe traumatic brain injury. J. Neurosurg., 119, 1583–1590.
4.
JosephB., AzizH., PanditV., KulvatunyouN., O'KeeffeT., WynneJ., TangA., FrieseR.S., and RheeP. (2014). Improving survival rates after civilian gunshot wounds to the brain. J Am Coll Surg. 218, 58–65.
5.
BeamanV., AnnestJ.L., MercyJ.A., KresnowM.J., and PollockD.A. (2000). Lethality of firearm-related injuries in the United States population. Ann. Emerg. Med., 35, 258–266.
6.
GressotL.V., ChamounR.B., PatelA.J., ValadkaA.B., SukiD., RobertsonC.S., and GopinathS.P. (2014). Predictors of outcome in civilians with gunshot wounds to the head upon presentation. J. Neurosurg., 121, 645–652.
7.
KhanM.B., KumarR., IrfanF.B., IrfanA.B., and BariM.E. (2014). Civilian craniocerebral gunshot injuries in a developing country: presentation, injury characteristics, prognostic indicators, and complications. World Neurosurg. 82, 14–19.
8.
PruittB. (2001). Part 2: prognosis in penetrating brain injury. J. Trauma, 51, S44–S86.
9.
DavisA.E. (2000). Mechanisms of traumatic brain injury: biomechanical, structural and cellular considerations. Crit. Care. Nurs. Q., 23, 1–13.
10.
XiongY., MahmoodA., and ChoppM. (2013). Animal models of traumatic brain injury. Nat. Rev. Neurosci., 14, 128–142.
11.
OehmichenM. and MeissnerC. (2009). Routine techniques in forensic neuropathology as demonstrated by gunshot injury to the head. Leg. Med. (Tokyo), 11, S50–S53.
12.
de LanerolleN.C., KimJ.H., and BandakF.A. (2015). Neuropathology of traumatic brain injury: comparison of penetrating, nonpenetrating direct impact and explosive blast etiologies. Semin. Neurol., 35, 12–19.
13.
AndriessenT.M., JacobsB., and VosP.E. (2010). Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J. Cell Mol Med., 14, 2381–2392.
14.
BullockR., ZaunerA., MyserosJ.S., MarmarouA., WoodwardJ.J., and YoungH.F. (1995). Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events. Ann. N. Y. Acad. Sci., 765, 290–298.
15.
SignorettiS., MarmarouA., AygokG.A., FatourosP.P., PortellaG., and BullockR.M. (2008). Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy. J. Neurosurg., 108, 42–52.
DasM., MohapatraS., and MohapatraS.S. (2012). New perspectives on central and peripheral immune responses to acute traumatic brain injury. J. Neuroinflammation, 9, 236.
18.
KeaneR.W., KraydiehS., LotockiG., AlonsoO.F., AldanaP., and DietrichW.D. (2001). Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J. Cereb. Blood Flow Metab., 21, 1189–1198.
19.
BramlettH.M. and DietrichW.D. (2007). Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog. Brain Res., 161, 125–141.
20.
BramlettH.M. and DietrichW.D. (2015). Long-term consequences of traumatic brain injury: current status of potential mechanisms of injury and neurological outcomes. J. Neurotrauma, 32, 1834–1848.
21.
RamlackhansinghA.F., BrooksD.J., GreenwoodR.J., BoseS.K., TurkheimerF.E., KinnunenK.M., GentlemanS, HeckemannR.A., GunanayagamK., GelosaG., and SharpD.J. (2011). Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 70, 374–383.
22.
BramlettH.M. and DietrichW.D. (2004). Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow and Metab., 24, 133–150.
23.
de Rivero VaccariJ.P., LotockiG., AlonsoO.F., BramlettH.M., DietrichW.D., and KeaneR.W. (2009). Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J. Cereb. Blood Flow and Metab., 29, 1251–1261.
24.
TomuraS., de Rivero VaccariJ.P., KeaneR.W., BramlettH.M., and DietrichW.D. (2012). Effects of therapeutic hypothermia on inflammasome signaling after traumatic brain injury. J. Cereb. Blood Flow Metab., 32, 1939–1947.
25.
LiuH.D., LiW., ChenZ.R., HuY.C., ZhangD.D., ShenW., ZhouM.L., ZhuL., and HangCH. (2013). Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem. Res., 38, 2072–2083.
26.
de Rivero VaccariJ.P., DietrichW.D., and KeaneR.W. (2014). Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J. Cereb. Blood Flow Metab., 34, 369–375.
27.
MaJ., XiaoW., WangJ., WuJ., RenJ., HouJ., GuJ., FanK., and YuB. (2016). Propofol inhibits NLRP3 inflammasome and attenuates blast-induced traumatic brain injury in rats. Inflammation, 39, 2094–2103.
MaM. W., WangJ., DhandapaniK.M., and BrannD.W. (2017). NADPH oxidase 2 regulates NLRP3 inflammasome activation in the brain after traumatic brain injury. Oxid. Med. Cell. Longev., 2017, 605769.
30.
AdamczakS., DaleG., de Rivero VaccariJ.P., BullockM.R., DietrichW.D., and KeaneR.W. (2012). Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. J. Neurosurg., 117, 1119–1125.
31.
de Rivero VaccariJ.P., BrandF., AdamczakS., LeeS.W., BarcenaJ.P., WangM.Y., BullockM.R., DietrichW.D., and KeaneR.W. (2015). Exosome-mediated inflammasome signaling after central nervous system injury. J. Neurochem., 136, S39–S48.
32.
WallischJ.S., SimonD.W., BayırH., BellM.J., KochanekP.M., and ClarkR.S.B. (2017). Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children. Neurocrit. Care, 27, 44–50.
33.
SilvermanW. R., de Rivero VaccariJ.P., LocoveiS., QiuF., CarlssonS.K., ScemesE., KeaneR.W., and DahlG. (2009). The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J. Biol. Chem., 284, 18143–18151.
34.
de Rivero VaccariJ.P., LotockiG., MarcilloA.E., DietrichW.D., and KeaneR.W. (2008). A molecular platform in neurons regulates inflammation after spinal cord injury. J. Neurosci., 28, 3404–3414.
35.
MinkiewiczJ., de Rivero VaccariJ.P., and KeaneR.W. (2013). Human astrocytes express a novel NLRP2 inflammasome. Glia, 61, 1113–1121.
36.
HalleA., HornungV., PetzoldG.C., StewartC.R., MonksB.G., ReinheckelT., FitzgeraldK.A., LatzE., MooreK.J., and GolenbckD.T. (2008). The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol., 9, 857–865.
37.
OkamotoM., LiuW., LuoY., TanakaA., CaiX., NorrisD.A., DinarelloC.A., and FujitaM., (2010). Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J. Biol. Chem., 285, 6477–6488.
38.
Fernandes-AlnemriT., WuJ., YuJ.W., DattaP., MillerB., JankowskiW., RosenbergS., ZhangJ., and AlnemriE.S. (2007). The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14, 1590–1604.
39.
Fernandes-AlnemriT., YuJ.W., DattaP., WuJ., and AlnemriE.S. (2009). AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature, 458, 509–513.
40.
HeW.T., WanH., HuL., ChenP., WangX., HuangZ., YangZ.H., ZhongC.Q., and HanJ. (2015). Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 25, 1285–1298.
41.
LiuX., ZhangZ., RuanJ., PanY., MagupalliV. G., WuH., and LiebermanJ. (2016). Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature, 535, 153–158.
42.
WilliamsA.J., HartingsJ.A., LuX.C. M., RolliM. L., DaveJ.R., and TortellaF.C. (2005). Characterization of a new rat model of penetrating ballistic brain injury. J. Neurotrauma, 22, 313–331.
43.
BrunsJ. and HauserW.A. (2003). The epidemiology of traumatic brain injury: a review. Epilepsia, 44, S2–S10.
44.
WilliamsA.J., WeiH.H., DaveJ.R., and TortellaF.C. (2007). Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat. J. Neuroinflammation, 4, 17.
45.
YaoC., WilliamsA.J., OttensA.K., May LuX.C., ChenR., WangK.K., HayesR.L., TortellaF.C., and DaveJ.R. (2008). Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats. Brain Inj. 22, 723–732.
46.
WeiH.H., LuX.C.M., ShearD.A., WaghrayA., YaoC., TortellaF.C., and DaveJ.R. (2009). NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats. J. Neuroinflammation, 6, 19.
47.
CartagenaC.M., PhillipsK.L., WilliamsG.L., KonopkoM., TortellaF.C., DaveJ.R., and SchmidK.E. (2013). Mechanism of action for NNZ-2566 anti-inflammatory effects following PBBI involves upregulation of immunomodulator ATF3. Neuromolecular Med. 15, 504–514.
48.
GildaJ.E., and GomesA.V. (2013). Stain-free total protein staining is a superior loading control to β-actin for Western blots. Anal. Biochem., 440, 186–188.
49.
GildaJ.E. and GomesA.V. (2015). Western blotting using in-gel protein labeling as a normalization control: stain-free technology. Methods Mol. Biol., 1295, 381–391.
50.
ThackerJ.S., YeungD.H., StainesW.R., and MielkeJ.G. (2016). Total protein or high-abundance protein: Which offers the best loading control for Western blotting?. Anal. Biochem., 496, 76–78.
51.
ChenW. and XuW.H. (2015). β-Actin as a loading control: less than 2 μg of total protein should be loaded. Electrophoresis, 36, 2046–2049.
52.
AdamczakS.E., de Rivero VaccariJ.P., DaleG., BrandF.J., NonnerD., BullockM.R., DahlG.P., DietrichW.D., and KeaneR.W. (2014). Pyroptotic neuronal cell death mediated by the AIM2 inflammasome. J. Cereb. Blood Flow Metab., 34, 621–629.
53.
Torres-PlatasS.G., ComeauS., RachalskiA., BoG.D., CruceanuC., TureckiG., GirosB., and MechawarN., (2014). Morphometric characterization of microglial phenotypes in human cerebral cortex. J. Neuroinflammation, 11, 12.
54.
SimonD.W., McGeachyM.J., BayırH., ClarkR.S.B., LoaneD.J., and KochanekP.M. (2017). The far-reaching scope of neuroinflammation after traumatic brain injury. Nat. Rev. Neurol., 13, 171–191.
55.
GyonevaS. and RansohoffR.M. (2015). Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines. Trends Pharmacol. Sci., 36, 471–480.
56.
FannD.Y.W., LeeS.Y., ManzaneroS., ChunduriP., SobeyC.G., and ArumugamT.V. (2013). Pathogenesis of acute stroke and the role of inflammasomes. Ageing Res. Rev., 12, 941–966.
57.
SongL., PeiL., YaoS., WuY., and ShangY. (2017). NLRP3 inflammasome in neurological diseases, from functions to therapies. Front. Cell. Neurosci., 11, 63.
58.
YangS.J., ShaoG.F., ChenJ.L., and GongJ. (2017). The NLRP3 inflammasome: an important driver of neuroinflammation in hemorrhagic stroke. Cell. Mol. Neurobiol., 265, 22–29.
59.
JassamY.N., IzzyS., WhalenM., McGavernD.B., and Khoury ElJ. (2017). Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron, 95, 1246–1265.
60.
TaabazuingC.Y., OkondoM.C., and BachovchinD.A. (2017). Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages. Cell Chem. Biol., 24, 507–514.
61.
FinkS.L. and CooksonB.T. (2005). Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun., 73, 1907–1916.
62.
LuX.C. M., ChenR.W., YaoC., WeiH., YangX., LiaoZ., DaveJ.R., and TortellaF.C. (2009). NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury. J. Neurotrauma, 26, 141–154.
63.
CartagenaC.M., SchmidK.E., PhillipsK.L., TortellaF.C., and DaveJ.R. (2013). Changes in apoptotic mechanisms following penetrating ballistic-like brain injury. J. Mol. Neurosci., 49, 301–311.
64.
IrreraN., PizzinoG., CalòM., PallioG., ManninoF., FamàF., ArcoraciV., FodaleV., DavidA., FrancescaC., MinutoliL., MazzonE., BramantiP., SquadritoF., AltavillaD., and BittoA. (2017). Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury. Front. Pharmacol., 8, 459.
65.
TanM.S., YuJ.T., JiangT., ZhuX.C., and TanL. (2013). The NLRP3 inflammasome in Alzheimer's disease. Mol. Neurobiol., 48, 875–882.
66.
ZhouY., LuM., DuR.-H., QiaoC., JiangC.Y., ZhangK.Z., DingJ.H., and GangH. (2016). MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease. Mol. Neurodegener., 11, 28.
67.
SarkarS., MalovicE., HarishchandraD.S., GhaisasS., PanickerN., CharliA., PalanisamyB.N., RokadD., JinH., AnantharamV., KanthasamyA., and KanthasamyA.G. (2017). Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease. NPJ Parkinsons Dis. 3, 30.
68.
BlockM.L., ZeccaL., and HongJ.S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci., 8, 57–69.
69.
DuL., ZhangY., ChenY., ZhuJ., YangY., and ZhangH.L. (2016). Role of microglia in neurological disorders and their potentials as a therapeutic target. Mol. Neurobiol., 274, 1–18.
70.
LoaneD. J. and KumarA. (2016). Microglia in the TBI brain: The good, the bad, and the dysregulated. Exp. Neurol., 275, 316–327.
71.
KabbaJ.A., XuY., ChristianH., RuanW., ChenaiK., XiangY., ZhangL., SaavedraJ.M., and PangT. (2017). Microglia: housekeeper of the central nervous system. Cell. Mol. Neurobiol.1–19.
72.
VarnumM.M. and IkezuT. (2012). The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain. Arch. Immunol. Ther. Exp. (Warsz), 60, 251–266.
73.
HanischU.K. (2013). Functional diversity of microglia - how heterogeneous are they to begin with?. Front. Cell. Neurosci., 7, 65.
74.
HellwigS., HeinrichA., and BiberK. (2013). The brain's best friend: microglial neurotoxicity revisited. Front. Cell. Neurosci., 7, 71.
75.
JiK.A., YangM.S., JeongH.K., MinK.J., KangS.H., JouI., and JoeE.H. (2007). Resident microglia die and infiltrated neutrophils and monocytes become major inflammatory cells in lipopolysaccharide-injected brain. Glia, 55, 1577–1588.
76.
DjukicM., MildnerA., SchmidtH., CzesnikD., BrückW., PrillerJ., NauR., and PrinzM. (2006). Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain, 129, 2394–2403.
77.
WilliamsA.J., HartingsJ.A., LuX.C.M., RolliM. L., and TortellaF.C. (2006). Penetrating ballistic-like brain injury in the rat: differential time courses of hemorrhage, cell death, inflammation, and remote degeneration. J. Neurotrauma, 23, 1828–1846.
78.
GajavelliS., KentaroS., DiazJ., YokoboriS., SpurlockM., DiazD., JacksonC., WickA., ZhaoW., LeungL.Y., ShearD., TortellaF., and BullockM.R. (2015). Glucose and oxygen metabolism after penetrating ballistic-like brain injury. J. Cereb. Blood Flow Metab., 35, 773–780.
79.
DonatC.K., ScottG., GentlemanS.M., and SastreM. (2017). Microglial Activation in Traumatic Brain Injury. Front. Aging Neurosci., 9, 208.
FreemanL.C. and TingJ.P.Y. (2016). The pathogenic role of the inflammasome in neurodegenerative diseases. J. Neurochem., 136, S29–S38.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
